insights_auto
Why is ONCY down 7.12%?
Dive Deeperchevron_right
ONCY:NASDAQ
Oncolytics Biotech Inc
$0.59
arrow_downward
-7.12%(-0.045) 1D
Oct 5, 12:53:32 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
$0.64
High
$0.64
Low
$0.58
Mkt. cap
74.85M
Avg. vol.
966.94K
Volume
1.15M
52-wk high
$1.42
52-wk low
$0.58
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
Open
$0.64
High
$0.64
Low
$0.58
Mkt. cap
74.85M
Avg. vol.
966.94K
Volume
1.15M
52-wk high
$1.42
52-wk low
$0.58
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
News stories
From web sources and news partners
AD HOC NEWS
·
7 hours ago
Oncolytics Biotech stock tracks REO 033 progress toward year end
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Websiteoncolyticsbiotech.com